GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 26 weeks on 1.7mg, full numbers, ask me anything boring — 49 comments in the full submission. View in context.
2.4k
c/retatrutide·submitted 7 months ago by u/emil_agyeman

[Results] 26 weeks on 1.7mg, full numbers, ask me anything boring

Resultsbranch of 8 comments

26 weeks on 1.7mg, full numbers, ask me anything boring. Full detail below, and I have tried to keep the editorialising out of it. To save the first four comments: 26 weeks and 1.7mg. The thing that surprised me was how much of the discussion here is inference rather than measurement. Kept a log specifically because…

Read the full submission and all 49 comments →

This branch

8 comments, started 7 months ago
u/nikhil_lindqvist238 points·7 months ago

Glucagon receptor agonism is associated with increased energy expenditure and with hepatic effects. That is a mechanistic story with strong preclinical support and limited phase 2 human data.

replysharereportpermalink
u/trialwatch_theoMOD125 points·7 months ago

Left up. It reads the phase 2 paper carefully and it is honest about the intervals.

replysharereportpermalink
u/two_mil_or_one47 points·7 months ago

Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.

replysharereportpermalink
u/cold_chromatogram_only38 points·7 months ago

comparing reta phase 2 to sema phase 3 is comparing different things

replysharereportpermalink
u/noor_ivaturi20 points·7 months ago

not approved anywhere, which is the single most important fact in this board

replysharereportpermalink
u/solene_ilunga50 points·7 months ago

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

replysharereportpermalink
u/yannick_salinas115 points·7 months ago

Agreed on the heart-rate reports. They are consistent enough across the threads to be worth noting, not enough to be a finding.

replysharereportpermalink
[removed]85 points·7 months ago

[removed by moderator]

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.